Dominari Holdings Inc
NASDAQ:DOMH

Watchlist Manager
Dominari Holdings Inc Logo
Dominari Holdings Inc
NASDAQ:DOMH
Watchlist
Price: 4.065 USD -0.85% Market Closed
Market Cap: $65.1m

Operating Margin

-56.1%
Current
Improving
by 3 374.6%
vs 3-y average of -3 430.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-56.1%
=
Operating Income
$-55.8m
/
Revenue
$99.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-56.1%
=
Operating Income
$-55.8m
/
Revenue
$99.6m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Dominari Holdings Inc
NASDAQ:DOMH
63.3m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 82% of companies in the United States of America
Percentile
18th
Based on 14 112 companies
18th percentile
-56.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Dominari Holdings Inc
Glance View

Market Cap
65.1m USD
Industry
Biotechnology

Dominari Holdings Inc., formerly AIkido Pharma Inc., is a biotechnology company. The Company has a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The Company’s pipeline consists of patented technology from universities and researchers. The Company advances its therapeutic drug pipeline through a collaboration with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is also developing a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Its pancreatic drug candidate, DHA-dFdC, is a chemotherapy treatment for advanced pancreatic cancer.

DOMH Intrinsic Value
15.03 USD
Undervaluation 73%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-56.1%
=
Operating Income
$-55.8m
/
Revenue
$99.6m
What is Dominari Holdings Inc's current Operating Margin?

The current Operating Margin for Dominari Holdings Inc is -56.1%, which is above its 3-year median of -3 430.6%.

How has Operating Margin changed over time?

Over the last 2 years, Dominari Holdings Inc’s Operating Margin has increased from -30 114.3% to -56.1%. During this period, it reached a low of -30 114.3% on Jun 30, 2023 and a high of -56.1% on Oct 30, 2025.

Back to Top